HSBC Holdings
NVO

HSBC Holdings’s Novo Nordisk NVO Stock Holding History

HSBC Holdings’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.7M Buy
899,804
+440,571
+96% +$20.9M 0.02% 620
2025
Q4 		$23.4M Sell
459,233
-203
-0% -$10.4K 0.01% 696
2025
Q3 		$25.3M Buy
459,436
+121,191
+36% +$7.09M 0.01% 647
2025
Q2 		$23.2M Buy
338,245
+59,686
+21% +$4.06M 0.01% 663
2025
Q1 		$19.2M Sell
278,559
-19,915
-7% -$1.64M 0.01% 725
2024
Q4 		$25.6M Buy
298,474
+167,685
+128% +$18.1M 0.01% 672
2024
Q3 		$15.5M Buy
130,789
+75,985
+139% +$10.1M 0.01% 799
2024
Q2 		$7.85M Buy
54,804
+8,922
+19% +$1.18M ﹤0.01% 926
2024
Q1 		$5.89M Sell
45,882
-20,638
-31% -$2.46M ﹤0.01% 1042
2023
Q4 		$6.88M Buy
66,520
+3,534
+6% +$349K 0.01% 1032
2023
Q3 		$5.73M Sell
62,986
-615,880
-91% -$54.3M 0.01% 1036
2023
Q2 		$55M Buy
678,866
+622,160
+1,097% +$50.8M 0.06% 334
2023
Q1 		$4.51M Buy
56,706
+616
+1% +$43.7K 0.01% 1153
2022
Q4 		$3.79M Sell
56,090
-20,310
-27% -$1.19M ﹤0.01% 1388
2022
Q3 		$3.81M Sell
76,400
-6,094
-7% -$326K 0.01% 1288
2022
Q2 		$4.59M Buy
82,494
+4,160
+5% +$231K 0.01% 1233
2022
Q1 		$4.35M Buy
78,334
+1,572
+2% +$80.7K 0.01% 1240
2021
Q4 		$4.3M Buy
76,762
+8,490
+12% +$460K ﹤0.01% 1329
2021
Q3 		$3.28M Sell
68,272
-780
-1% -$37.7K ﹤0.01% 1330
2021
Q2 		$2.89M Sell
69,052
-3,108
-4% -$120K ﹤0.01% 1300
2021
Q1 		$2.43M Buy
72,160
+58,894
+444% +$2.1M ﹤0.01% 1240
2020
Q4 		$463K Sell
13,266
-5,014
-27% -$173K ﹤0.01% 2254
2020
Q3 		$634K Buy
18,280
+3,470
+23% +$116K ﹤0.01% 1787
2020
Q2 		$485K Sell
14,810
-4,360
-23% -$139K ﹤0.01% 1854
2020
Q1 		$577K Sell
19,170
-2,492
-12% -$74.2K ﹤0.01% 1717
2019
Q4 		$626K Sell
21,662
-2,370
-10% -$65.6K ﹤0.01% 2107
2019
Q3 		$621K Sell
24,032
-2,212
-8% -$55.9K ﹤0.01% 2209
2019
Q2 		$670K Sell
26,244
-3,352
-11% -$82.8K ﹤0.01% 1940
2019
Q1 		$774K Buy
29,596
+19,300
+187% +$474K ﹤0.01% 1949
2018
Q4 		$237K Buy
10,296
+1,274
+14% +$28.3K ﹤0.01% 2404
2018
Q3 		$212K Sell
9,022
-6,710
-43% -$164K ﹤0.01% 2399
2018
Q2 		$362K Sell
15,732
-7,996
-34% -$190K ﹤0.01% 2201
2018
Q1 		$584K Buy
23,728
+10,494
+79% +$276K ﹤0.01% 1872
2017
Q4 		$355K Sell
13,234
-6,396
-33% -$163K ﹤0.01% 1641
2017
Q3 		$473K Buy
19,630
+2,252
+13% +$50.9K ﹤0.01% 1739
2017
Q2 		$372K Sell
17,378
-3,730
-18% -$75.3K ﹤0.01% 1784
2017
Q1 		$362K Sell
21,108
-38,890
-65% -$677K ﹤0.01% 1721
2016
Q4 		$1.08M Buy
59,998
+8,108
+16% +$147K ﹤0.01% 1395
2016
Q3 		$1.08M Buy
51,890
+42,724
+466% +$1.06M ﹤0.01% 1332
2016
Q2 		$247K Sell
9,166
-1,198
-12% -$32.9K ﹤0.01% 1843
2016
Q1 		$281K Sell
10,364
-65,854
-86% -$1.76M ﹤0.01% 1775
2015
Q4 		$2.22M Buy
76,218
+2,736
+4% +$75.7K 0.01% 1230
2015
Q3 		$1.99M Sell
73,482
-17,460
-19% -$494K 0.01% 1065
2015
Q2 		$2.49M Buy
90,942
+7,592
+9% +$213K 0.01% 1017
2015
Q1 		$2.23M Sell
83,350
-11,800
-12% -$272K ﹤0.01% 1151
2014
Q4 		$2.01M Buy
95,150
+79,804
+520% +$1.78M ﹤0.01% 1155
2014
Q3 		$366K Buy
+15,346
New +$353K ﹤0.01% 1536

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

HSBC Holdings's NVO Position: Q1 2026 in Review

HSBC Holdings increased its Novo Nordisk (NVO) stake by 96% in Q1 2026, buying an estimated $20.9M and bringing the position to 899,804 shares worth $32.7M. The position accounts for 0.02% of the portfolio, ranked #620.

HSBC Holdings first reported a position in NVO in Q3 2014 and has held it in 47 quarters since. The position peaked at $55M in Q2 2023. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • HSBC Holdings held 899,804 shares of Novo Nordisk worth $32.7M as of Q1 2026.
  • HSBC Holdings bought 440,571 Novo Nordisk shares in Q1 2026, an estimated $20.9M.
  • Novo Nordisk made up 0.02% of HSBC Holdings's portfolio in Q1 2026, its #620 holding.
  • HSBC Holdings first reported a position in Novo Nordisk in Q3 2014 and has held it in 47 quarters since.
  • HSBC Holdings's Novo Nordisk position peaked at $55M in Q2 2023.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.